The antifungal eugenol perturbs dual aromatic and branched-chain amino acid permeases in the cytoplasmic membrane of yeast E Darvishi, M Omidi, AAS Bushehri, A Golshani, ML Smith PloS one 8 (10), e76028, 2013 | 95 | 2013 |
Thymol antifungal mode of action involves telomerase inhibition E Darvishi, M Omidi, AA Bushehri, A Golshani, ML Smith Medical mycology 51 (8), 826-834, 2013 | 34 | 2013 |
Englerin A inhibits EWS-FLI1 DNA binding in Ewing sarcoma cells V Caropreso, E Darvishi, TJ Turbyville, R Ratnayake, PJ Grohar, ... Journal of Biological Chemistry 291 (19), 10058-10066, 2016 | 33 | 2016 |
Effects of different hormone treatments on nonembryogenic and embryogenic callus induction and time-term enzyme treatments on number and viability of isolated protoplasts in … E Darvishi, R Zarghami, CA Mishani, M Omidi II International Symposium on Saffron Biology and Technology 739, 279-284, 2006 | 26 | 2006 |
Madecassic acid derivatives as potential anticancer agents: synthesis and cytotoxic evaluation ASC Valdeira, E Darvishi, GM Woldemichael, JA Beutler, KR Gustafson, ... Journal of natural products 82 (8), 2094-2105, 2019 | 20 | 2019 |
In vitro production of pathogen-free plantlets via meristem culture in saffron (Crocus sativus L.). E Darvishi, R Zarghami, CA Mishani, M Omidi, A Sarkhosh | 16 | 2006 |
Anti-cancer activity of ST101, a novel antagonist of CCAAT/enhancer binding protein β. E Darvishi, L Ghamsari, SF Leong, R Ramirez, M Koester, E Gallagher, ... Molecular Cancer Therapeutics 21 (11), 1632–1644, 2022 | 6 | 2022 |
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas E Darvishi, K Slemmons, Z Wan, S Mitra, X Hou, JH Parmentier, YHE Loh, ... Neoplasia 22 (7), 274-282, 2020 | 6 | 2020 |
Cycloheximide inhibits actin cytoskeletal dynamics by suppressing signaling via RhoA E Darvishi, GM Woldemichael Journal of Cellular Biochemistry 117 (12), 2886-2898, 2016 | 5 | 2016 |
Investigation of the best time of enzyme treatment in order to isolate the protoplast from embryogenic callus of saffron (Crocus sativus L.). E Darvishi, R Zarghami, CA Mishani, M Omidi, A Sarkhosh | 4 | 2006 |
Abstract LB045: β-catenin antagonist peptide, ST316, attenuates Wnt-dependent oncogenic activity L Ghamsari, E Gallagher, E Darvishi, S Leong, M Koester, R Ramirez, ... Cancer Research 82 (12_Supplement), LB045-LB045, 2022 | | 2022 |
Abstract LB206: Characterizing the PK/PD relationship of C/EBPβ antagonist peptide ST101 in a mouse orthotopic breast cancer model J Rotolo, M Koester, R Ramirez, E Gallagher, L Ghamsari, S Leong, ... Cancer Research 82 (12_Supplement), LB206-LB206, 2022 | | 2022 |
Abstract P5-08-08: C/EBPβ antagonist peptide, ST101, as a novel therapeutic for breast cancer J Rotolo, M Koester, R Ramirez, S Leong, L Ghamsari, E Gallagher, ... Cancer Research 82 (4_Supplement), P5-08-08-P5-08-08, 2022 | | 2022 |
CELL-PENETRATING PEPTIDE ANTAGONIST OF CCAAT/ENHANCER BINDING PROTEIN SS DISPLAYS POTENT ANTI-GLIOBLASTOMA ACTIVITY J Rotolo, L Ghamsari, R Ramierez, M Koester, S Leong, E Gallagher, ... NEURO-ONCOLOGY 23, 80-81, 2021 | | 2021 |
Mithramycin-A Induced Toxicity in HepG2 Cells is mediated by Disruption of Calcium Homeostasis E Darvishi, JB Lissoos, CL Thomas, GM Woldemichael Journal of Pharmacology and Pharmaceutical Research 2 (1), 1–8, 2019 | | 2019 |
Calmodulin governs nuclear entry of fusion PAX3/FOXO1 oncoprotein, a target in alveolar rhabdomyosarcoma E Darvishi, CL Thomas, BE Gryder, JF Shern, J Khan, GM Woldemichael Cancer Research 78 (13_Supplement), 890-890, 2018 | | 2018 |
Mithramycin Revisited: Exploring the Mechanism of Toxicity in Failure of a Phase I Clinical Trial J Lissoos, E Darvishi, G Woldemichael 2017 AIChE Annual Meeting, 2017 | | 2017 |
Pharmacology and Ethnopharmacology GM Woldemichael, E Darvishi | | 2016 |
CHEMICAL-GENETIC PROFILE ANALYSIS OF EUGENOL INSACCHAROMYCES CEREVISIAE E DARVISHI, M OMIDI, ALIA BOOSHEHRI, A GOLSHANI, M SMITH | | 2013 |
A Survey of High-Throughput Technologies in the Development of New Therapeutic Agents E Darvishi, M Omidi, A Bushehri Genetics in the Third Millennium 11 (2), 2013 | | 2013 |